Episode Summary
Prof Dorothy Keefe, CEO of Cancer Australia, and Mark Scott discuss the COVID impact on diagnosing and treating lung cancer patients – a 4 week delay in diagnosis makes a difference. The red flag symptoms of lung cancer need increased education, especially for the younger, non-smoking women, who are not always aware that a lung cancer diagnosis is possible. GP awareness and early screening is also important here. We are very good at treating breast cancer, colorectal cancer and prostate cancer – we need more focus to reach this point with lung cancer. Developing a specific thoracic oncology research group will enable such a focus, especially a multidisciplinary, patient centric group such as TOGA.
Show Hosts
This episode’s host are:
- Prof Dorothy Keefe, CEO, Cancer Australia; honorary Clinical Professor, the School of Medicine, University of Adelaide; Professor of Cancer Medicine, University of Adelaide; Senior Medical Oncologist, Royal Adelaide Hospital
- Mark Scott
